Search

The document titled "Non-serious case reports" provides a list of drugs associated with non-serious adverse events found in recent scientific literature. The table includes the names of the drugs, the adverse events reported, and the number of cases. Some of the drugs mentioned include Adenosine, Alirocumab, Amoxicillin/clavulanic acid, Cefalexin, Asciminib, Avelumab, and many others. The adverse events range from signs and symptoms to skin disorders, respiratory signs, and injection site pain. This information can be useful for library patrons conducting research on specific drugs and their potential side effects. [Extracted from the article]

In a study involving 115 patients with anemia who received intravenous iron therapy, six patients experienced gastrointestinal effects, low fever, or thrombocytopenia during treatment with iron-sucrose. The study did not provide specific information about the dosages, duration of treatment, or outcomes of these reactions. This information may be useful for library patrons researching the potential side effects of iron-sucrose therapy for anemia. [Extracted from the article]

This document provides a list of recently published scientific literature on drug safety-related topics. The articles cover a range of subjects, including the incidence of thiazide-induced hyponatremia, the safety of SARS-CoV-2 vaccines in patients with Wilson's disease, the correlation of Esketamine with specific adverse events, the safety of therapeutic drugs for breast cancer patients, the effects of cannabis exposure on pregnancy outcomes, and the discontinuation rate and adverse events of chemoimmunotherapy for triple-negative breast cancer. These articles may be of interest to library patrons conducting research on these specific topics. [Extracted from the article]

A recent study published in Reactions Weekly examined the efficacy of cyclophosphamide in patients with refractory/relapsing lymphoma who underwent high-dose chemotherapy followed by autologous haematopoietic stem cell transplantation (HSCT). The study included 36 patients, and one patient was found to have a lack of efficacy with cyclophosphamide when used as prophylaxis against acute graft versus-host disease (GVHD). The patient's age, sex, route of administration, and dosage were not specified in the study. This information may be useful for library patrons researching the effectiveness of cyclophosphamide in this specific context. [Extracted from the article]

A case report from a prospective observational study describes a patient who experienced bradycardia after receiving dexmedetomidine for anesthesia during upper limb surgery. The patient received lidocaine at the clavicle's junction and then dexmedetomidine with ropivacaine for a supraclavicular block. The onset and outcome of the bradycardia are not specified. This information may be useful for library patrons researching the effects of dexmedetomidine during anesthesia. [Extracted from the article]

This document provides a list of recently published scientific literature on drug safety. The articles cover a range of topics, including the comparative safety of different doses of sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes, the risk of serotonin syndrome with drugs affecting serotonin levels, the association of anticholinergic drug exposure with dementia risk in older adults in Japan, the incidence of adverse events in Japanese and non-Japanese subjects in phase I studies, and the comparative safety of antidepressants in adults with chronic kidney disease. These articles may be of interest to library patrons conducting research on these specific topics. [Extracted from the article]

This document provides a list of drugs associated with non-serious adverse events identified in the scientific literature over the last week. The table includes the drug names, the adverse events reported, and the number of cases. Some of the drugs mentioned include Abatacept, Alogliptin, Baricitinib, and Insulin aspart. Adverse events range from cough and stomatitis to abnormal laboratory parameters and hypersensitivity. This information can be useful for library patrons conducting research on specific drugs and their potential side effects. [Extracted from the article]

The document titled "Non-serious case reports" provides a list of drugs associated with non-serious adverse events found in recent scientific literature. The table includes the drug names, the adverse events reported, and the number of cases for each event. Some of the drugs mentioned include alirocumab, amphotericin B, asparaginase, atezolizumab, and many others. The adverse events range from fatigue and fever to skin disorders and gastrointestinal issues. This information can be useful for library patrons researching specific drugs and their potential side effects. [Extracted from the article]

In a retrospective study of 33 patients with psoriasis, three patients were described who experienced adverse effects while being treated with etanercept. Patient 1 developed lethargy, Patient 2 experienced worsening pancytopenia, and Patient 3 had worsening transaminitis. Patient outcomes and specific treatment details were not provided in the study. It is important for library patrons to be aware of potential side effects when considering etanercept as a treatment option for psoriasis. [Extracted from the article]

This document provides a list of drugs associated with non-serious adverse events identified in scientific literature over the past week. The table includes the names of the drugs, the adverse events reported, and the number of cases. Some of the drugs mentioned include Abiraterone, Enzalutamide, Leuprorelin, Radium 223 chloride, Amikacin, Pyrazinamide, Amoxicillin, Anastrozole, Tamoxifen, and many others. Adverse events range from fatigue, pain, and sleep disorders to hearing loss, hyperuricaemia, and hypersensitivity. This information can be useful for library patrons conducting research on specific drugs and their associated adverse events. [Extracted from the article]

In a study conducted in South Korea, a case of endophthalmitis was reported in a patient receiving treatment with aflibercept, a medication used for certain eye conditions. The patient received an intravitreal injection of aflibercept, but subsequently developed endophthalmitis. The outcome of the case was not specified. This information may be of interest to library patrons researching the potential side effects of aflibercept or seeking information on endophthalmitis. [Extracted from the article]

The document titled "Non-serious case reports" provides a list of drugs associated with non-serious adverse events found in scientific literature over the past week. The table includes the drug names, the adverse events, and the number of cases reported. Some of the drugs mentioned include Amitriptyline, Amoxicillin, Ascorbic acid, Azithromycin, Capecitabine, and many others. The adverse events range from sleep disorders and exanthema to joint disorders and skin disorders. This information can be useful for library patrons conducting research on specific drugs and their potential side effects. [Extracted from the article]